Showing results (1301-1310 of 1,520) with videos related to

Sort By:
Pageof 152
Endocrine-Related Cancer|May 28, 2004
High-resolution serum proteomic features for ovarian cancer detectionT P Conrads, V A Fusaro, S Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Designing phase 0 cancer clinical trialsAnthony J Murgo, Shivaani Kummar, Larry Rubinstein, et al.
JAMA Dermatology|February 26, 2025
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical TrialAndrea M Gross, Olivia H Reid, Lauren A Baldwin, et al.
American Journal of Hematology|January 7, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosisSencer Goklemez, Annie P Im, Liang Cao, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Journal of Postgraduate Medicine|November 6, 2014
Pre-injury neuro-psychiatric medication use, alone or in combination with cardiac medications, may affect outcomes in trauma patientsJ R Wisler, A N Springer, K Hateley, et al.
Journal of Cancer|June 7, 2012
A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as BiomarkersRussell C Langan, John E Mullinax, Satyajit Ray, et al.
Cancer Research|January 5, 2012
Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damageDaniel P Fitzgerald, Preeti Subramanian, Monika Deshpande, et al.
American Journal of Human Genetics|February 25, 2014
Exome-based mapping and variant prioritization for inherited Mendelian disordersDaniel C Koboldt, David E Larson, Lori S Sullivan, et al.
The Lancet. Oncology|April 6, 2015
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker studyMark Roschewski, Kieron Dunleavy, Stefania Pittaluga, et al.
Pageof 152